Medical researchers continue to make strides in the battle to control cancer. A Seattle-based biotech company has developed a drug that is showing promise for treatment of lymphoma, a form of cancer that attacks the body’s immune system.
Gilead Sciences has been testing an oral drug called idelalisib. It works to inhibit development of P13K deltas, a group of enzymes commonly found in B-cell malignancies, which make up the majority of non-Hodgkin lymphoma cases. A recent study was conducted through the Clinical Research Division of Fred Hutchinson Cancer Research Center, also located in Seattle.
The focus group was comprised of 125 patients between the ages of 33 and 87 who were diagnosed with indolent non-Hodgkin lymphoma. This particular form, also known as slow-growing, is difficult to treat as the disease often becomes resistant to therapy. After receiving twice-daily doses of idelalisib, 57 percent of the patients saw their tumors shrink by at least half while six percent showed no measurable evidence of cancer.
According to Ajay Gopal, M.D., lead researcher in the study, the patients had exhausted all current means of therapy and several had relapsed. One of the more encouraging results was the relative lack of side effects, unlike chemotherapy treatments. The most common side effects were diarrhea and colitis, which were successfully managed by adjusting the dosage. While it doesn’t appear that idelalisib is a cure, researchers are hopeful that it will be a valuable treatment for controlling lymphoma for extended periods.
Our alternative cancer treatment center uses programs of non-toxic immunotherapy tailored to your individual needs. Many of our patients have achieved long-term remission of lymphoma and other forms. Please visit our website for more information.
Heat is one of the body’s primary defense mechanisms against disease. It is the reason you run a fever when you’re fighting the flu or an infection. Heating cells well beyond their normal tolerance can eliminate the harmful substances that are making you ill.
What Is Hyperthermia?
Hyperthermia, also called Thermal Therapy, is rooted in this natural defensive strategy and can be a valuable component of integrative cancer treatment. In hyperthermia, the entire body or the diseased portions of the body are purposefully heated to produce a therapeutic response.
The use of fever therapy can be traced back to the early Greeks and Romans. Hippocrates, the father of medicine, wrote, “Give me the power to produce fever, and I will cure all disease.”
Over the centuries, fever therapy has been a common disease treatment used by Native Americans, Chinese, Japanese and 18th century Europeans. In the 19th century, German physicians saw sarcoma regression or cure in patients who had endured high fevers from infectious diseases.
Hyperthermia and Cancer
Hyperthermia continues to be a valid disease-fighting treatment. Beginning in the 1950s, our founder Dr. Josef M. Issels administered fever therapy to thousands of cancer patients with remarkable results. There is continued and strong evidence that hyperthermia stimulates and regulates the immune system and is especially beneficial to cancer patients.
Visit our website to find out more about hyperthermia and other alternative cancer treatments.
No other disease carries the aura of fear and panic associated with cancer. Until recently a cancer diagnosis was considered a death warrant. But new discoveries and a move toward integrative cancer treatments have pushed back the shroud of death, extending the average cancer survival rate from 5 to 10 years – and many patients are living decades longer. Cancer deaths in the U.S. have been declining steadily over the past 20 years. Today, integrative immunotherapy offers even stage 4 cancer patients real hope of long-term remission.
Stage 4 Transformation
Many stage 4 cancer patients turn to Issels alternative cancer treatment centers after traditional cancer treatments have failed. They arrive at our clinics sick and in despair. Many are too ill to walk or talk. Moving beyond standard treatments is an act of desperation — a final grasp at life – as it was for Jim Gibson. Jim’s decision to seek integrative immunotherapy for recurrent small cell lung cancer was a last resort that proved to be both life-saving and life changing. Four weeks after beginning Issels Treatment®, Jim achieved complete remission. Now 10 years cancer-free, Jim leads a healthy active life.
From Desperation to Hope
Jim’s story is not unique among Issels’ patients. We urge you to listen to our patients’ stories. Each story is a tale of desperation transformed by hope under the care of Issels compassionate staff. While each patient’s story is unique; many, including patients with stage 4 cancer, have achieved complete and long-term remission of their cancer as a result of Issels non-toxic individualized immunotherapy.
The positive results being achieved with integrative immunotherapy are leading more cancer patients to choose immunotherapy as a primary treatment. As our patient Nicole revealed in her video, “It would be so nice if I had come here first.”
“When 14-year-old Nick Wilkins’ leukemia resisted chemotherapy, radiation and a bone marrow transplant, his doctors turned to the real pros: Nick’s own immune cells,” John Bonifield of CNN recently wrote on Click2Houston.com. After two months of targeted immunotherapy, Nick’s cancer “went into complete remission.”
Nick’s experience was not unique. Eighteen of the 21 other young cancer patients participating in a University of Pennsylvania study on the effectiveness of immunotherapy-based advanced targeted therapies also experienced complete remission of their cancer.
“This is absolutely one of the more exciting advances I’ve seen in cancer therapy in the last 20 years,” Dr. David Porter, Penn hematologist and oncologist, told CNN. “We’ve entered into a whole new realm of medicine.”
While some of the approaches to targeted cancer therapy are certainly new – recent advances in cellular and genetic medicine have made it possible to target specific genes and cell functions at a level not previously available – employing the body’s immune system to target cancer is a tried and true, rather than a “new,” approach. Issels Integrative Oncology Centers have been using individualized immunotherapy to treat cancer for more than 60 years! (Learn more about Issels’ history.)
Penn cancer researchers are not the only ones belatedly recognizing the advantages the immune system offers in the fight against cancer. In an earlier post on targeted therapy, we quoted immunologist Gordon Freeman of Boston’s Dana-Farber Cancer Institute, who presaged the Penn findings when he said:
“The immune system is an evolutionary learning system. If you can engage it and get it to work successfully, it learns how to attack the cancer. And the wonderful thing is that it works.”
Visit our website to find out about integrative immunotherapy, a safe, effective, non-toxic way to treat cancer that is revolutionizing cancer treatment.
The scent of cancer caused a national ruckus recently when a New Mexico school principal banned a mother with stage 4 breast cancer from participating in school activities with her children (see our November 18, 2013 tweets). Why? School staff complained about her smell!
The incident raised the ire of people in the woman’s own community and across the nation. Messages poured in condemning the principal’s decision and supporting the cancer patient and her family. The take-away message was that cancer patients and their families rely on and profit from the support of their families, friends and community; but the incident also piqued people’s curiosity. Does cancer affect the way a person smells?
Body odor is the natural result of the expulsion of waste products through our breath, blood, urine and skin. The way we smell can be affected by changes in body chemistry. Certain dietary practices, diseases and medications are known to cause changes in body scent. Chemotherapy appears to have been the cause of the chemical scent that created so much trouble for the New Mexico mom. But the evidence linking cancer to scent is largely experiential.
Organic chemist George Preti of the Monell Chemical Senses Center, who has spent more than 40 years studying human scent, hopes to change that. Working with an interdisciplinary team from the University of Pennsylvania, Preti is now attempting to identify the scent of cancer, specifically ovarian cancer. If Preti’s team is successful, the ability to scent cancer in its early stages before it is detectable by other methods could prove to be a powerful diagnostic tool.
Big Pharma is jumping on the immunotherapy band wagon. According to Bloomberg.com, major drug companies are poised to introduce a new generation of experimental cancer drugs that use the immune system to target and destroy tumor cells. Big Pharma may be putting a new twist on immunotherapy, but the treatment philosophy is hardly new. Alternative cancer treatment centers were early to recognize the importance the human immune system plays in fighting cancer. Immune-boosting cancer vaccines and integrative immunotherapy have been cornerstones of Issels Integrative Oncology treatment protocols for 60 years.
Motivated by billions of dollars in potential drug sales, drug companies are waiting for study results scheduled for presentation at the annual meeting of the American Society of Clinical Oncology at the end of May before launching new drugs.
[Immunotherapy] “is going to be a paradigm shift for treating cancer. We are pretty good at shrinking tumors but not good at getting rid of them. Immune therapy is a way to begin to approach that,” Merck VP Gary Gilliland told Bloomberg.
Drug makers estimate it will take a year to determine the effectiveness of new immunotherapy drugs to increase cancer survival rates and extend lives. Bloomberg notes “the strategy offers scientists the first major new avenue for attacking cancer in a decade.”
Rather than waiting for Big Pharma to complete its testing, we’d like to recommend that people with cancer review the patient testimonials on our website. We’ve been using immunotherapy to fight cancer for more than 60 years and many of our patients have enjoyed complete long-term cancer remissions. Visit our website to hear what they have to say.